Alpha 2.0
Login Register
» Authors » Silke Heldwein

Silke Heldwein

Explore the profile of Silke Heldwein including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 75
Followers 0
Related Specialties
Infectious Diseases
Microbiology
Gastroenterology
Top 10 Co-Authors
Eva Wolf
Sebastian Noe
Ariane Von Krosigk
Hans Jaeger
Carmen Wiese
Rita Pascucci
Celia Oldenbuettel
Farhad Schabaz
Celia Jonsson-Oldenbuettel
Christoph D Spinner
Published In
Liver Int
Infect Dis Rep
Infection
Antivir Ther
Horm Metab Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Humoral response to SARS-CoV-2 vaccines in people living with HIV
Noe S, Ochana N, Wiese C, Schabaz F, Von Krosigk A, Heldwein S, et al.
Infection . 2021 Oct; 50(3):617-623. PMID: 34694595
Purpose: To describe the humoral immune response to COVID-19 vaccines in people living with HIV and identify factors associated with the magnitude of anti-SARS-CoV-2 antibody concentrations. Methods: Retrospective analysis of...
2.
Tenofovir Disoproxil Fumarate Is Associated with a Set-Point Variation in the Calcium-Parathyroid Hormone-Vitamin D Axis: Results from a German Cohort
Noe S, Heldwein S, Wiese C, Pascucci R, Von Krosigk A, Schabaz F, et al.
Adv Pharmacol Sci . 2019 Jan; 2018:6069131. PMID: 30687401
Background: Higher levels of parathyroid hormone have been associated with the use of tenofovir disoproxil fumarate (TDF) in people with and without HIV infection. Yet, alterations in calcium levels have...
3.
Secondary Hyperparathyroidism in HIV-Infected Patients in Central Europe
Noe S, Oldenbuettel C, Heldwein S, Wiese C, Von Krosigk A, Pascucci R, et al.
Horm Metab Res . 2018 Jan; 50(4):317-324. PMID: 29361637
Secondary hyperparathyroidism (sHPT) might be a contributor to increased risk of osteoporosis in adult HIV patients but there is little data available on this issue in this particular population. The...
4.
Patterns of vitamin D, parathyroid hormone and c-terminal telopeptide of collagen type 1 in Caucasian and African descent HIV-infected populations in Central Europe
Noe S, Oldenbuettel C, Heldwein S, Jaeger H, Wolf E
Infect Dis Rep . 2017 Oct; 9(3):7265. PMID: 29071047
Risk factors for bone loss in HIV patients might differ or have a different impact in African descent compared to Caucasian populations. The aim of the paper is to analyze...
5.
Cholecalciferol 20 000 IU Once Weekly in HIV-Positive Patients with Low Vitamin D Levels: Result from a Cohort Study
Noe S, Heldwein S, Pascucchi R, Oldenbuttel C, Wiese C, Von Krosigk A, et al.
J Int Assoc Provid AIDS Care . 2017 Apr; 16(4):315-320. PMID: 28393662
Purpose: To evaluate efficacy and safety of 20 000 IU cholecalciferol weekly in HIV-infected patients. Methods: Longitudinal data for 243 HIV-infected patients with paired 25-OH-vitamin D3 values for the same...
6.
Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results
Oldenbuettel C, Wolf E, Ritter A, Noe S, Heldwein S, Pascucci R, et al.
Antivir Ther . 2016 Sep; 22(2):169-172. PMID: 27588613
Background: The potential toxicity of long-term antiretroviral therapy (ART) requires ongoing investigation of novel strategies for treatment of HIV-infected patients. Monotherapy with the integrase inhibitor (INSTI) dolutegravir (DTG) may offer...
7.
K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells
Freise C, Heldwein S, Erben U, Hoyer J, Kohler R, Johrens K, et al.
Liver Int . 2014 Sep; 35(4):1244-52. PMID: 25212242
Background & Aims: In liver fibrosis, activated hepatic stellate cells (HSC) secrete excess extracellular matrix, thus, represent key targets for antifibrotic treatment strategies. Intermediate-conductance Ca(2) (+) -activated K(+) -channels (KCa3.1)...